imiquimod has been researched along with Colorectal Cancer in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Chen, Y; Huang, Y; Jia, Z; Liu, J; Liu, Y; Wen, Y; Yuan, X | 1 |
| Lang, T; Li, Y; Wu, T; Yan, W; Yin, Q; Yuan, W; Zhu, R; Zou, Y | 1 |
| Culbert, A; Jiang, X; Kaufmann, M; Lin, W; Luo, T; Ni, K | 1 |
| Hu, J; Liu, F; Liu, X; Sun, J; Wang, X; Yu, S; Yu, W; Zhao, Y | 1 |
| Dong, Z; Han, X; Liu, Z; Peng, R; Wang, C; Xu, J; Xu, L; Yang, R; Zhu, W; Zhuang, Q | 1 |
| Bogeschdorfer, F; Gronau, S; Riechelmann, H | 1 |
| Donahue, RN; McLaughlin, PJ; Rogosnitzky, M; Zagon, IS | 1 |
1 review(s) available for imiquimod and Colorectal Cancer
| Article | Year |
|---|---|
[New substances in the therapy of head and neck cancer].
Topics: Administration, Oral; Aminoquinolines; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Basal Cell; Carcinoma, Non-Small-Cell Lung; Cetuximab; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Controlled Clinical Trials as Topic; Double-Blind Method; Erlotinib Hydrochloride; Fibroblast Growth Factor 7; Gefitinib; Head and Neck Neoplasms; Humans; Imiquimod; Infusions, Intravenous; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Ointments; Protein Kinase Inhibitors; Quinazolines; Radioimmunotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms; Time Factors; United States; United States Food and Drug Administration | 2006 |
6 other study(ies) available for imiquimod and Colorectal Cancer
| Article | Year |
|---|---|
Bidirectional anisotropic palladium nanozymes reprogram macrophages to enhance collaborative chemodynamic therapy of colorectal cancer.
Topics: Catalase; Colorectal Neoplasms; Humans; Hyaluronic Acid; Hydrogen Peroxide; Imiquimod; Macrophages; Mannose; Neoplasms; Oxygen; Palladium; Reactive Oxygen Species; Tumor Microenvironment | 2022 |
Co-delivering irinotecan and imiquimod by pH-responsive micelle amplifies anti-tumor immunity against colorectal cancer.
Topics: Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Colorectal Neoplasms; Hydrogen-Ion Concentration; Imiquimod; Irinotecan; Mice; Micelles | 2023 |
Nanoscale Metal-Organic Framework Co-delivers TLR-7 Agonists and Anti-CD47 Antibodies to Modulate Macrophages and Orchestrate Cancer Immunotherapy.
Topics: Animals; Antibodies; CD47 Antigen; Cell Line, Tumor; Colorectal Neoplasms; Imiquimod; Immunity, Innate; Immunotherapy; Macrophages; Metal-Organic Frameworks; Mice; Nanostructures; Neoplasms, Experimental; Toll-Like Receptor 7 | 2020 |
Treating Immunologically Cold Tumors by Precise Cancer Photoimmunotherapy with an Extendable Nanoplatform.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colorectal Neoplasms; Hyaluronic Acid; Imiquimod; Immunotherapy; Indocyanine Green; Mice; Nanoparticles; Optical Imaging; Particle Size; Phototherapy; Surface Properties; Zeolites | 2020 |
Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer.
Topics: Animals; Cell Line, Tumor; Chlorophyllides; Colonic Neoplasms; Colorectal Neoplasms; CTLA-4 Antigen; Disease Models, Animal; Female; HeLa Cells; Humans; Imiquimod; Immunotherapy; Mice; Mice, Inbred BALB C; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Porphyrins | 2017 |
Imiquimod upregulates the opioid growth factor receptor to inhibit cell proliferation independent of immune function.
Topics: Adenocarcinoma; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Head and Neck Neoplasms; Humans; Imiquimod; Immunity; Narcotic Antagonists; Pancreatic Neoplasms; Receptors, Opioid; RNA, Small Interfering; Up-Regulation | 2008 |